Imagen de Portada

The Silver Jubilee (2025) of Insulin Glargine: Introducing the Era of Long‐Acting Insulin Analogues for Diabetes Mellitus

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Geremia B. Bolli, Philip D. Home, Mauro Lepore, Matthew C. Riddle, Francesca Porcellati, Carmine G. Fanelli, Paola Lucidi, Hannele Yki‐Järvinen, Reinhard H. Becker, David R. Owens
Formato:	Artículo Open Access
Publicado:	Wiley 2026
Materias:	Diabetes, Obesity and Metabolism
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

An overview of randomized clinical trials of fixed‐ratio combinations of basal insulin plus GLP ‐ 1RA (injectable therapy): Lessons for advancing therapy in people with type 2 diabetes
por: Geremia B. Bolli, et al.
Publicado: (2025)

Clinical Outcomes With Once‐Weekly Insulin Icodec Versus Once‐Daily Insulin Glargine U100 in Insulin‐Naïve and Previously Insulin‐Treated Individuals With Type 2 Diabetes: A Meta‐Analysis of Randomised Controlled Trials
por: Mushood Ahmed, et al.
Publicado: (2024)

Simplified Switching to Once‐Weekly Insulin Icodec Without an Initial One‐Time Additional Dose Versus Once‐Daily Insulin Glargine U100 in Basal Insulin‐Treated Type 2 Diabetes ( ONWARDS 10): A Randomised Controlled Trial
por: Julio Rosenstock, et al.
Publicado: (2026)

Importance of targeting post‐prandial hyperglycaemia to achieve HbA1c goals in insulin glargine‐treated subphenotypes of type 2 diabetes
por: Wolfgang Landgraf, et al.
Publicado: (2025)

Insulin Inertia Among People With Type 2 Diabetes Mellitus in Qatar: The INERT‐Q Study
por: Mohammed Bashir, et al.
Publicado: (2024)

Glycaemic Control According to the Final Insulin Dose Using an Innovative Fixed‐Dose Titration of Weekly Insulin Efsitora in Insulin‐Naïve Type 2 Diabetes
por: Lisa Connery, et al.
Publicado: (2026)

Investigating the Correlation Between Cognitive Function and Fasting Blood Sugar, Fasting Insulin Level and Insulin Sensitivity in Patients With Multiple Sclerosis
por: Nasim Rezaeimanesh, et al.
Publicado: (2024)

Obesity as the Upstream Driver of Inflammation and Insulin Resistance in Hyperuricaemia
por: Mohammad Riashad Monjur
Publicado: (2026)

Once‐Weekly Insulin Versus Once‐Daily Insulin for Type 1 Diabetes Treatment: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials
por: Obieda Altobaishat, et al.
Publicado: (2025)

Glucocorticoid‐Induced Hyperglycaemia in Hospital: The Insulin Dose Matters Most
por: Morton G. Burt, et al.
Publicado: (2026)

Efficacy and Safety of Once‐Weekly and Once‐Daily Basal Insulins in Type 1 Diabetes Mellitus: A Systematic Review and Network Meta‐Analysis of Clinical Trials
por: Ricardo Amaral, et al.
Publicado: (2026)

Insulin glargine 300 U/ mL safety data in pregnancy
por: Jukka Westerbacka, et al.
Publicado: (2025)

Association Analysis of Insulin Resistance Metabolic Score (METS‐IR) and Gestational Diabetes Mellitus: Based on National Health and Nutrition Examination Survey Database From 2007 to 2018
por: Hou Wenxuan, et al.
Publicado: (2025)

Ethical Challenges in Automated Insulin Delivery and Emerging Diabetes Technologies
por: Ralph El Khoury, et al.
Publicado: (2026)

The Effect of Metformin on Insulin Requirement, Glycaemic Control and Weight Gain in Type 1 Diabetes During Pregnancy—a Randomised, Placebo‐Controlled Multicentre Study
por: Elina Juuma, et al.
Publicado: (2025)

Evaluating Intensive Insulin Therapy With Empagliflozin in Type 2 Diabetes: A Randomised Study
por: Nobutoshi Fushimi, et al.
Publicado: (2025)

Insulin Sensitive Patients With Impaired Glucose Tolerance: Physiologic and Metabolic Characterization ( STOP DIABETES )
por: John Armato, et al.
Publicado: (2026)

Anthropometric and Biochemical Correlations of Insulin Resistance in a Middle-Aged Maltese Caucasian Population
por: Rachel Agius, et al.
Publicado: (2024)

An overview of insulin therapy for the non‐specialist
por: Philip D. Home
Publicado: (2025)

High‐Protein Diet Exacerbates Insulin Resistance via the JNK / IKKβ ‐ IRS ‐1 Pathway
por: Junjun Li, et al.
Publicado: (2025)

Antidiabetic Potential of Brewed Arabica Coffee: Modulation of GLUT4, Insulin, and Glucagon in STZ‐Induced Rats
por: Yusni Yusni, et al.
Publicado: (2026)

Cost‐Effectiveness of Control‐ IQ + Technology in Insulin‐Treated Patients With Type 2 Diabetes in the United States
por: Neda Al Rawashdh, et al.
Publicado: (2026)

Insulin requirements during pregnancy in women with type 1 diabetes treated with insulin pump
por: Nimrod Dori‐Dayan, et al.
Publicado: (2024)

Glycemic Control During the Menstrual Cycle in Women With Type 1 Diabetes: Performance of an Automated Insulin Delivery System
por: Tatiana Rojas López, et al.
Publicado: (2026)

A Novel Method to Evaluate Insulin Sensitivity by Combining Continuous Glucose Monitoring and Urinary C‐Peptide Excretion
por: Guillermo Sanchez‐Delgado, et al.
Publicado: (2026)

Comparative Determination of Mitochondrial Biomarkers and Their Relationship With Insulin Resistance in Type 2 Diabetic Patients: An Observational Cross‐Sectional Study
por: Emmanuel K. Ofori, et al.
Publicado: (2024)

Glycaemic outcomes in adults with type 2 diabetes over 34 weeks with the Omnipod® 5 Automated Insulin Delivery System
por: Georgia M. Davis, et al.
Publicado: (2024)

Review of Associations of Diabetes and Insulin Resistance With Brain Health in Three Harmonised Cohort Studies of Ageing and Dementia
por: Roshni Biswas, et al.
Publicado: (2025)

Cost‐Effectiveness of Automated Insulin Delivery Systems in Paediatrics, T1D and T2D Adults Across Four Nordic Countries
por: Johan Jendle, et al.
Publicado: (2026)

The Efficacy of Imeglimin and Metformin on Insulin Sensitivity and Secretion Using Oral Minimal Model: Sub‐Analysis of an Exploratory Randomised Controlled Trial
por: Ryota Usui, et al.
Publicado: (2026)

GIP in Cardiovascular and Kidney Disease: From Physiology to Pharmacology
por: Michelantonio De Fano, et al.
Publicado: (2026)

Exploring Combined Use of Continuous Glucose Monitoring and Anti‐Diabetes Medications on Glycaemic Control for People With Type 2 Diabetes Not Using Insulin
por: Poorva M. Nemlekar, et al.
Publicado: (2025)

Long‐Term Low‐Dose of Nitrate Administration Improves Antioxidant Defence System in Insulin‐Sensitive Tissues of Type 2 Diabetic Rats
por: Fatemeh Ghorbani, et al.
Publicado: (2026)

Exploring Insulin Resistance in Adults With Type 1 Diabetes: The Role of the Estimated Glucose Disposal Rate and the Triglyceride Glucose Index
por: Silvia Angelino, et al.
Publicado: (2025)

Body Composition and Regional Adiposity in Adolescents With Type 1 Diabetes: Relation to Insulin Resistance, Glycaemic Control and Vascular Complications
por: Safinaz Adel Elhabashy, et al.
Publicado: (2025)

Glycaemic Metrics Improve Significantly Within 7 Days of Continuous Glucose Monitoring Initiation in Non‐Insulin–Using People With Type 2 Diabetes
por: Holly J. Willis, et al.
Publicado: (2026)

Insulin therapy DE ‐ intensificAtion with iGlarLixi : A phase 4, open‐label, parallel‐group randomised controlled trial
por: Peter Novodvorský, et al.
Publicado: (2025)

Comparison of Glucose Management Between Open‐Source Loop and Tandem Control‐ IQ Automated Insulin Delivery Systems in Adults With Type 1 Diabetes
por: Zekai Wu, et al.
Publicado: (2026)

Function of PNPLA3 I148M —Lessons From In Vivo Studies in Humans
por: Hannele Yki‐Järvinen, et al.
Publicado: (2025)

Interactions of the Osteokines, Glucose/Insulin System and Vascular Risk Networks in Patients With Newly Diagnosed Type 2 Diabetes (VNDS 15)
por: Chiara Zusi, et al.
Publicado: (2024)